Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
MLSS · against 22 other Healthcare companies of similar size
Ranked #13 of 23 · scores higher than 18% of peers
Bars: peers in each 10-point band of the valuation score11 peers with a valuation score of 0–9, including MLSS · Click a bar to see the companies
Mainly because of its EBITDA yield and earnings yield, which are weaker than most Healthcare peers.
| Metric | MLSS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 22 reported | -16.7% | -77.4% | 81% | 30% | |
| EBITDA yieldHigher is better · 29 reported | -15.6% | -10.9% | 39% | 50% | |
| Free cash flow yieldHigher is better · 16 reported | -2.4% | -87.0% | 93% | 20% | |
| Book yieldHigher is better · 26 reported | 13.0% | 111.0% | 12% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 272M HKD (≈$35M) | 97 | 59 | |
| 2 | 5.6B JPY (≈$38M) | 88 | 55 | |
| 3 | 211M MYR (≈$46M) | 74 | 65 | |
| 4 | 3.5B JPY (≈$24M) | 65 | 48 | |
| 5 | 30M USD | 33 | ||
| 13 | 250M SEK (≈$25M) | 8 | 44 | |
| 13 | 17M USD | 8 | 18 | |
| 13 | 390.5B IDR (≈$24M) | 8 | 8 | |
| 13 | 298M SEK (≈$30M) | 8 | 48 | |
| 13 | 27M USD | 8 | 24 | |
| 20 | 252M HKD (≈$32M) | 0 | 17 | |
| 20 | 276M SEK (≈$28M) | 0 | 48 | |
| 20 | 22M AUD (≈$15M) | 0 | 25 | |
| 20 | 271M SEK (≈$27M) | 0 | 41 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score